Investor profile
Aphelion Capital
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Aphelion Capital is a healthcare venture capital firm that invests in capital-efficient medical technologies and services with a novel approach to healthcare delivery. The firm targets early and mid-stage medical device and digital health companies whose products improve patient outcomes at the same or lower cost to the healthcare system, emphasizing financial discipline and shorter timelines to market. Aphelion's strategy rests on four pillars: Innovation (embracing companies improving clinical outcomes through entrepreneurship), Excellent People & Teams (partnering with exceptional teams passionate about solving healthcare problems), Economics (investing in ideas that deliver better outcomes at the same or lower cost), and Collaborative Capital (providing meaningful support through an extensive network and active strategic limited partners including the American Heart Association, UPMC Enterprises, and Philips).
Notable quotes
“We are committed to investing in low capital-intensive entrepreneurial opportunities that will improve health care quality while reducing costs in our health care system.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Neura Health | Series A | $11m | 2025-09-01 |
| Laplace Interventional | Series C | $22m | 2025-03-01 |
| Biolinq | Series C | — | 2025-03-07 |
| Nectero Medical | Series D | $96m | 2024-04-01 |
| Vertos Medical | Series C | $26m | 2023-06-01 |
| Silk Road Medical | IPO | — | — |
| Relievant Medsystems | Acquisition | $850m | 2023-01-01 |
| Eargo | IPO | — | — |
| Freespira | Series B+ | — | — |
| Minerva Surgical | Series B+ | — | — |
Frequent co-investors
Fit check
Is Aphelion Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit